Kruskal–Wallis test analysis showed that the levels of HOTTIP and KPNA3 in the tumor tissues of patients with recurrent CRC who received mitomycin treatment were higher than those in tumor tissues of patients with primary CRC. This evidence concerns the gene KPNA3 and colorectal carcinoma.